Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
A. Kofoed-Enevoldsen, T. Deckert & L. Bent-H Ansen. (1992) Transcapillary filtration of plasma protein in long-term type 1 (insulin dependent) diabetic patients. Scandinavian Journal of Clinical and Laboratory Investigation 52:7, pages 591-597.
Read now
Read now
Anders Fomsgaard, Leif Bæk, Jonna Storm Fomsgaard & Allan Engquist. (1989) Preliminary Study on Treatment of Septic Shock Patients with Antilipopolysaccharide IgG from Blood Donors. Scandinavian Journal of Infectious Diseases 21:6, pages 697-708.
Read now
Read now
Anders Fomsgaard & Bo Dinesen. (1987) Elisa for Human IgG and IpM Anti-Lipopolysaccharide Antibodies with Indirect Standardization. Journal of Immunoassay 8:4, pages 333-350.
Read now
Read now
Articles from other publishers (20)
Kasper Rossing, Per K. Christensen, Birgitte V. Hansen, Bendix Carstensen & Hans-Henrik Parving. (2003) Optimal Dose of Candesartan for Renoprotection in Type 2 Diabetic Patients With Nephropathy. Diabetes Care 26:1, pages 150-155.
Crossref
Crossref
Steen Andersen, Lise Tarnow, Francois Cambien, Peter Rossing, Tina R. Juhl, Jaap Deinum & Hans-Henrik Parving. (2002) Renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/deletion genotype?. Kidney International 62:1, pages 192-198.
Crossref
Crossref
Ilpo Ala‐Houhala, Matti Koskinen, Tapani Ahola, Aimo Harmoinen, Timo Kouri, Kaija Laurila, Jukka Mustonen & Amos Pasternack. (2002) Increased glomerular permeability in patients with nephropathia epidemica caused by Puumala hantavirus. Nephrology Dialysis Transplantation 17:2, pages 246-252.
Crossref
Crossref
Kasper Rossing, Per K. Christensen, Berit R. Jensen & Hans-Henrik Parving. (2002) Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy. Diabetes Care 25:1, pages 95-100.
Crossref
Crossref
Henrik P. Hansen, Peter Hovind, Berit R. Jensen & Hans-Henrik Parving. (2002) Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy. Kidney International 61:1, pages 163-168.
Crossref
Crossref
Timo Kouri, Aimo Harmoinen, Kaija Laurila, Ilpo Ala-Houhala, Timo Koivula & Amos Pasternack. (2001) Reference Intervals for the Markers of Proteinuria with a Standardised Bed-Rest Collection of Urine. Clinical Chemistry and Laboratory Medicine 39:5.
Crossref
Crossref
Steen Andersen, Lise Tarnow, Peter Rossing, Birgitte V. Hansen & Hans-Henrik Parving. (2000) Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney International 57:2, pages 601-606.
Crossref
Crossref
Melissa J. Burne, Tanya M. Osicka & Wayne D. Comper. (1999) Fractional clearance of high molecular weight proteins in conscious rats using a continuous infusion method. Kidney International 55:1, pages 261-270.
Crossref
Crossref
Sumi Hidaka, Oriyoshi Kaneko, Mikiko Shirai, Kenichiro Kojima, Yasuko Igarashi, Kuniyoshi Oda, Minoru Chimata, Kazumichi Nakamura & Mitsumasa Nagase. (1998) Do obesity and non-insulin dependent diabetes mellitus aggravate exercise-induced microproteinuria?. Clinica Chimica Acta 275:2, pages 115-126.
Crossref
Crossref
Allan Kofoed-EnevoldsenWendy-Jane FoyleMaryam FernandezJohn S. Yudkin. (1996) Evidence of Impaired Glomerular Charge Selectivity in Nondiabetic Subjects With Microalbuminuria. Arteriosclerosis, Thrombosis, and Vascular Biology 16:3, pages 450-454.
Crossref
Crossref
Jan Skov Jensen. (1995) Renal and Systemic Transvascular Albumin Leakage in Severe Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 15:9, pages 1324-1329.
Crossref
Crossref
J. S. JENSEN, K. BORCH‐JOHNSEN, T. DECKERT, M. DECKERT, G. JENSEN & B. FELDT‐RASMUSSEN. (2008) Reduced glomerular size‐ and charge‐selectivity in clinically healthy individuals with microalbuminuria. European Journal of Clinical Investigation 25:8, pages 608-614.
Crossref
Crossref
M. -A. Gall, P. Rossing, A. Kofoed-Enevoldsen, F. S. Nielsen & H. -H. Parving. (1994) Glomerular size-and charge selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 37:2, pages 195-201.
Crossref
Crossref
T. Deckert, A. Kofoed-Enevoldsen, P. Vidal, K. N�rgaard, H. B. Andreasen & B. Feldt-Rasmussen. (1993) Size- and charge selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 36:3, pages 244-251.
Crossref
Crossref
Raimund Hirschberg, Giuliano Brunori, Joel D. Kopple & Hans-Peter Guler. (1993) Effects of insulin-like growth factor I on renal function in normal men. Kidney International 43:2, pages 387-397.
Crossref
Crossref
H. -J. Bangstad, A. Kofoed-Enevoldsen, K. Dahl-J�rgensen & K. F. Hanssen. (1992) Glomerular charge selectivity and the influence of improved blood glucose control in Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 35:12, pages 1165-1169.
Crossref
Crossref
A FomsgaardB DinesenG H ShandT PresslerN Høiby. (1989) Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Journal of Clinical Microbiology 27:6, pages 1222-1229.
Crossref
Crossref
Carl Erik Mogensen & Ole Schrnitz. (1988) The Diabetic Kidney: From Hyperfiltration and Microalbuminuria to End-stage Renal Failure. Medical Clinics of North America 72:6, pages 1465-1492.
Crossref
Crossref
A FomsgaardN HøibyG H ShandR S ConradC Galanos. (1988) Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Infection and Immunity 56:9, pages 2270-2278.
Crossref
Crossref
Torsten Deckert, Bo Feldt-Rasmussen, René Djurup & Marja Deckert. (1988) Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney International 33:1, pages 100-106.
Crossref
Crossref